/PRNewswire/ Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today announced it has entered into an agreement.
Sartorius to acquire Novasep s chromatography process equipment division
USA - English
- Strengthens Sartorius position in downstream bioprocessing
News provided by
Share this article
Share this article
GÖTTINGEN, Germany, Jan. 6, 2021 /PRNewswire/ The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained. Novasep s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA, China and India. The proposed transaction is subject to antitrust approvals and the information and consultation of Novasep s works council and is expected to close during the